RAF-709 is a novel Raf kinase inhibitor used for the treatment of non-small cell lung cancer (NSCLC).
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Inflammation / Immunology | Raf
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.